Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medelle Corporation appears to be a small private U.S. medical device company focused on assisted-reproduction and embryo-culture products. Publicly available evidence links the company to intravaginal culture vessels, embryo/gamete handling labware, and related fertility-treatment tools marketed under the MEDELLE name. Patent and trademark records suggest the company developed container systems intended for incubation or storage of biological media, gametes, and embryos, indicating a niche position in IVF and reproductive-medicine workflows. Third-party company databases list the business as active, healthcare-related, and based in the Boston-area Massachusetts medical device cluster. The company does not appear to have a broad disclosed therapeutic pipeline typical of a drug developer; instead, it is better characterized as a reproductive-health medtech supplier.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medelle Corporation.